Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Taurochenodeoxycholic acid is a naturally occurring bile acid formed in the liver by conjugation of chenodeoxycholic acid with taurine. It acts as a bile salt, facilitating the emulsification and absorption of lipids such as cholesterol in the intestine. As a medication, it reduces cholesterol formation in the liver and is used primarily as a choleretic (to increase bile secretion) and cholagogue (to promote bile discharge into the duodenum). Taurochenodeoxycholic acid is also being investigated for its potential roles in inflammation and cancer therapy. Its mechanism of action includes acting as a detergent to solubilize fats and possibly modulating hepatocellular exocytosis via calcium-dependent pathways[1][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on taurochenodeoxycholic acid.